Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.

<h4>Background</h4>Pemphigus vulgaris (PV) is a rare autoimmune blistering disease characterized by the development of autoantibodies targeting desmoglein (Dsg) 3, but also against Dsg1 in mucocutaneous disease. Given that existing PV animal models only recapitulate aspects of the diseas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Katharina Boch, Sören Dräger, Detlef Zillikens, Christoph Hudemann, Christoph M Hammers, Sabrina Patzelt, Enno Schmidt, Ewan A Langan, Rüdiger Eming, Ralf J Ludwig, Katja Bieber
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3af1dc721abe47bead8a4b80c47ec50e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3af1dc721abe47bead8a4b80c47ec50e
record_format dspace
spelling oai:doaj.org-article:3af1dc721abe47bead8a4b80c47ec50e2021-12-02T20:04:26ZImmunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.1932-620310.1371/journal.pone.0259586https://doaj.org/article/3af1dc721abe47bead8a4b80c47ec50e2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0259586https://doaj.org/toc/1932-6203<h4>Background</h4>Pemphigus vulgaris (PV) is a rare autoimmune blistering disease characterized by the development of autoantibodies targeting desmoglein (Dsg) 3, but also against Dsg1 in mucocutaneous disease. Given that existing PV animal models only recapitulate aspects of the disease, we aimed to establish a more comprehensive disease model based on the immunization of mice with PV autoantigen(s).<h4>Methods</h4>The following immunization strategies were tested: (i) C57Bl/6J, B6.SJL-H2s C3c/1CyJ, DBA2/J, or SJL/J mice were immunized with recombinant murine Dsg3 (mDsg3), (ii) DBA2/J and SJL/J mice were immunized with mDsg3 and additionally injected a single non-blister inducing dose of exfoliative toxin A (ETA), and (iii) DBA2/J and SJL/J mice were immunized with human Dsg (hDsg) 1 and 3.<h4>Results</h4>Despite the induction of autoantibodies in each immunization protocol, the mice did not develop a clinical phenotype. Tissue-bound autoantibodies were not detected in the skin or mucosa. Circulating autoantibodies did not bind to the native antigen in indirect immunofluorescence microscopy using monkey esophagus as a substrate.<h4>Conclusion</h4>Immunization with PV autoantigens induced non-pathogenic Dsg1/3 antibodies, but did not cause skin/mucous membrane disease in mice. These findings, confirmed by failure of binding of the induced autoantibodies to their target in the skin, suggest that the autoantibodies which were formed were unable to bind to the conformational epitope present in vivo.Katharina BochSören DrägerDetlef ZillikensChristoph HudemannChristoph M HammersSabrina PatzeltEnno SchmidtEwan A LanganRüdiger EmingRalf J LudwigKatja BieberPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11, p e0259586 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Katharina Boch
Sören Dräger
Detlef Zillikens
Christoph Hudemann
Christoph M Hammers
Sabrina Patzelt
Enno Schmidt
Ewan A Langan
Rüdiger Eming
Ralf J Ludwig
Katja Bieber
Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
description <h4>Background</h4>Pemphigus vulgaris (PV) is a rare autoimmune blistering disease characterized by the development of autoantibodies targeting desmoglein (Dsg) 3, but also against Dsg1 in mucocutaneous disease. Given that existing PV animal models only recapitulate aspects of the disease, we aimed to establish a more comprehensive disease model based on the immunization of mice with PV autoantigen(s).<h4>Methods</h4>The following immunization strategies were tested: (i) C57Bl/6J, B6.SJL-H2s C3c/1CyJ, DBA2/J, or SJL/J mice were immunized with recombinant murine Dsg3 (mDsg3), (ii) DBA2/J and SJL/J mice were immunized with mDsg3 and additionally injected a single non-blister inducing dose of exfoliative toxin A (ETA), and (iii) DBA2/J and SJL/J mice were immunized with human Dsg (hDsg) 1 and 3.<h4>Results</h4>Despite the induction of autoantibodies in each immunization protocol, the mice did not develop a clinical phenotype. Tissue-bound autoantibodies were not detected in the skin or mucosa. Circulating autoantibodies did not bind to the native antigen in indirect immunofluorescence microscopy using monkey esophagus as a substrate.<h4>Conclusion</h4>Immunization with PV autoantigens induced non-pathogenic Dsg1/3 antibodies, but did not cause skin/mucous membrane disease in mice. These findings, confirmed by failure of binding of the induced autoantibodies to their target in the skin, suggest that the autoantibodies which were formed were unable to bind to the conformational epitope present in vivo.
format article
author Katharina Boch
Sören Dräger
Detlef Zillikens
Christoph Hudemann
Christoph M Hammers
Sabrina Patzelt
Enno Schmidt
Ewan A Langan
Rüdiger Eming
Ralf J Ludwig
Katja Bieber
author_facet Katharina Boch
Sören Dräger
Detlef Zillikens
Christoph Hudemann
Christoph M Hammers
Sabrina Patzelt
Enno Schmidt
Ewan A Langan
Rüdiger Eming
Ralf J Ludwig
Katja Bieber
author_sort Katharina Boch
title Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
title_short Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
title_full Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
title_fullStr Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
title_full_unstemmed Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
title_sort immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/3af1dc721abe47bead8a4b80c47ec50e
work_keys_str_mv AT katharinaboch immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
AT sorendrager immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
AT detlefzillikens immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
AT christophhudemann immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
AT christophmhammers immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
AT sabrinapatzelt immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
AT ennoschmidt immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
AT ewanalangan immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
AT rudigereming immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
AT ralfjludwig immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
AT katjabieber immunizationwithdesmoglein3inducesnonpathogenicautoantibodiesinmice
_version_ 1718375595239276544